Get the Stockscreener App
0.7921
10.73%
-0.0952
Glucotrack Inc stock is traded at $0.7921, with a volume of 121.54K.
It is down -10.73% in the last 24 hours and down -65.11% over the past month.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
See More
Previous Close:
$0.8873
Open:
$0.88
24h Volume:
121.54K
Relative Volume:
0.44
Market Cap:
$806.37K
Revenue:
$208.00K
Net Income/Loss:
$-16.89M
P/E Ratio:
-0.0379
EPS:
-20.8847
Net Cash Flow:
$-16.44M
1W Performance:
-28.64%
1M Performance:
-65.11%
6M Performance:
-92.92%
1Y Performance:
-99.25%
1-Day Range:
$0.76
$0.88
1-Week Range:
$0.8611
$1.1999
52-Week Range:
$0.76
$112.50
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.7921 | 806.37K | 208.00K | -16.89M | -16.44M | -20.88 |
ABT
Abbott Laboratories
|
104.67 | 181.11B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.62 | 122.32B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
292.96 | 112.37B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.84 | 63.53B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.63 | 49.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Glucotrack Inc Stock (GCTK) Latest News
Form 8K GlucoTrack Inc For: 28 September - Investing.com India
GlucoTrack Announces Debt-Reducing Public Equity Offering - theglobeandmail.com
Form 424B5 GlucoTrack Inc For: 24 September By Investing.com - Investing.com Canada
Medical device developer Glucotrack Inc. announces pricing of $3M public offering - ROI-NJ
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering - Yahoo Finance
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering - Business Wire
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack (NASDAQ: GCTK) registers shares equal to 5,442% of stock outstanding - Stock Titan
Form 8K GlucoTrack Inc For: 14 September By Investing.com - Investing.com India
Form 8K GlucoTrack Inc For: 14 September By Investing.com - Investing.com UK
Shareholders at Glucotrack (GCTK) sign off on new financing-linked share issuances - Stock Titan
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Australia
Why Is GlucoTrack (GCTK) in Focus? - kalkinemedia.com
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com India
Glucotrack Prices $11.5 Million Convertible Note Financing - minichart.com.sg
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Nigeria
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com South Africa
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Australia
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Canada
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com UK
Glucotrack Closes $11.6M Senior Secured Convertible Notes; Generates $4.5M Cash in Private Placement - TradingView
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com South Africa
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Nigeria
Glucotrack Secures $11.5 Million Convertible Debt Financing - citybiz
Glucotrack secures $11.5M in convertible note financing - Investing.com
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com India
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Canada
Glucotrack Announces $11.5 Million Financing - Finviz
Glucotrack Announces $11.5 Million Financing - marketscreener.com
Glucotrack Announces $11.5 Million Financing - Yahoo Finance
Why Does Glucotrack (NASDAQ:GCTK) Stand Out This Session? - kalkinemedia.com
GlucoTrack, Inc. announced that it has received $9.045015 million in funding - marketscreener.com
Glucotrack Strikes Settlement With Alto; $2M Cash Plus $2M Convertible Note at 5% - TradingView
Articles from Glucotrack - FinancialContent
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - kalkinemedia.com
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - Kalkine Media
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - 01net
Lōkahi Therapeutics Expands ai² Into Three Opportunity-Creating Business Divisions - Finviz
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - Stock Titan
GlucoTrack Inc (GCTK) Key Financial Ratios – Valuation, Profitability & More - Value Research
Glucotrack (NASDAQ: GCTK) Announces White Lion Capital's 9.99% Stake Comprising 79,734 Shares - kalkinemedia.com
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
Near-10% Glucotrack (GCTK) holder faces ~5% cap unless limits raised - Stock Titan
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - Kalkine Media
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business - FinancialContent
Lōkahi Therapeutics Expands Ai2 Futures Lab Asset Origination Network Through Collaboration With San Diego State University Fowler College of Business - Moomoo
What Is Driving Glucotrack Stock? (NASDAQ:GCTK) - Kalkine Media
GlucoTrack Inc (GCTK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Glucotrack (NASDAQ: GCTK) Executes 1-for-15 Reverse Stock Split, Reducing Shares to About 798,144 - Kalkine Media
What Is Driving Glucotrack Stock? - Kalkine Media
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
20.31%
3.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):